Oligonucleotide Therapeutics and Delivery Conference 2021
Evvnt Promotion / evvnt
Archive
22.09.2021 - 23.09.2021 Online
Time: 09:00 - 17:30
Conference themes
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered "non-draggable".
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered "non-draggable".
Professional congress organizer (PCO)
SMI Group Limited
SMI Group Limited
Enquiries and Registration:
https://go.evvnt.com/774501-0?pid=4832
Ms. Jinna Sidhu
General Medicine
Languages
English
English
Congress fees
Virtual attendance: GBP 999.00
Virtual attendance: GBP 999.00
Participants expected
150
150
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
